172@29@17@244!~!172@29@0@53!~!|news|business|aurobindo-pharma-to-acquire-certain-biz-assets-of-profectus-biosciences-4683981.html!~!news|moneycontrol|com!~!|controller|infinite_scroll_article.php!~!is_mobile=false
Moneycontrol
FREE virtual training session on Passive Income Secrets: October 24 and 25, 2020, 10am to 1pm. Register Now!
you are here: HomeNewsBusiness
Last Updated : Nov 28, 2019 08:05 PM IST | Source: PTI

Aurobindo Pharma to acquire certain biz assets of Profectus BioSciences

The acqusition provides access to proprietary and innovative technology platforms for prophylactic use and therapeutic use along with global R&D center, Aurobindo Pharma said.

PTI
Representative image
Representative image
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Aurobindo Pharma on November 28 said its subsidiary Auro Vaccines LLC has entered into a pact to acquire certain business assets from Profectus BioSciences Inc USA for an upfront cash consideration of $11.29 million (around Rs 80 crore) with potential earn-outs on achieving certain milestones. Auro Vaccines LLC is a wholly-owned subsidiary of Aurobindo Pharma USA Inc, USA, which is a wholly-owned arm of the company, Aurobindo Pharma said in a filing to the BSE.

The indicative time period for completion of acquisition of research and development assets of Profectus BioSciences Inc is first half of 2020, it added.

The acqusition provides access to proprietary and innovative technology platforms for prophylactic use and therapeutic use along with global R&D center, Aurobindo Pharma said.

Close

The acquisition will lead to enhancement of research and development capabilities and expertise in developing newer vaccines from basic discovery research into FDA-approved product, it added.

Shares of Aurobindo Pharma on Thursday closed 0.69 per cent lower at Rs 450.20 per scrip on the BSE.
First Published on Nov 28, 2019 07:58 pm
Sections